Donvito Giovanna, Maltecca Carlo, Hofer Sabine E, Meraner Dagmar, Siebert Uwe, Arvandi Marjan
Institute of Public Health, Medical Decision Making and Health Technology Assessment, Department of Public Health, Health Services Research and Health Technology Assessment, UMIT TIROL-University for Health Sciences and Technology, Hall in Tirol, Austria.
Department of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy.
Diabet Med. 2025 Oct;42(10):e70125. doi: 10.1111/dme.70125. Epub 2025 Aug 20.
Emerging adults with chronic diseases like diabetes often experience a decline in health during the process of transition from paediatric to adult healthcare. This study assesses the impact of transition on healthcare quality of people with diabetes, focusing on glycated haemoglobin (HbA).
We conducted a systematic review and meta-analysis of the difference in HbA before and after transition following the PRISMA guidelines. A comprehensive search across four databases for studies of diabetes type 1 and 2 published between 2018 and 2024 was conducted. Risk of bias was assessed using the ROBINS-I tool for non-randomized studies.
Twenty studies were included in the systematic review, fifteen to the meta-analysis. Eleven studies considered a structured or semi-structured transition programme: three reported a reduction in HbA (improved glycaemic control) and eight no significant difference. Nine studies considered no transition programme: four showed a worsening of glycaemic control and five no significant difference. Overall, the meta-analysis showed a worsening of glycaemic control post-transition with mean difference (MD) -1.75 mmol/mol (-0.16%) [95% confidence interval (CI) -5.24-1.75 mmol/mol (-0.48%-0.16%)], with considerable heterogeneity, where negative values indicate higher HbA post-transition. Subgroup analysis for transition programmes and usual care showed, respectively, significant improvement and worsening of glycaemic control with MD of 3.28 mmol/mol (0.30%) [95% CI 0.44-6.12 mmol/mol (0.04%-0.56%)] and -6.99 mmol/mol (-0.64%) [95% CI -11.79 to -2.19 mmol/mol (-1.08% to -0.20%)].
Findings suggest that the transition to adult care may negatively affect glycaemic control in emerging adults with diabetes, whereas structured transition programmes can neutralize this effect and prevent consequences. Further investigations are needed to develop evidence-based guidelines for optimizing transition interventions.
患有糖尿病等慢性病的青少年在从儿科医疗过渡到成人医疗的过程中,健康状况往往会下降。本研究评估了过渡对糖尿病患者医疗质量的影响,重点关注糖化血红蛋白(HbA)。
我们按照PRISMA指南对过渡前后HbA的差异进行了系统评价和荟萃分析。对四个数据库进行了全面检索,以查找2018年至2024年发表的1型和2型糖尿病研究。使用ROBINS-I工具对非随机研究进行偏倚风险评估。
系统评价纳入了20项研究,荟萃分析纳入了15项。11项研究考虑了结构化或半结构化过渡计划:3项报告HbA降低(血糖控制改善),8项无显著差异。9项研究未考虑过渡计划:4项显示血糖控制恶化,5项无显著差异。总体而言,荟萃分析显示过渡后血糖控制恶化,平均差(MD)为-1.75 mmol/mol(-0.16%)[95%置信区间(CI)-5.24-1.75 mmol/mol(-0.48%-0.16%)],存在相当大的异质性,负值表明过渡后HbA更高。过渡计划和常规护理的亚组分析分别显示血糖控制有显著改善和恶化,MD分别为3.28 mmol/mol(0.30%)[95%CI 0.44-6.12 mmol/mol(0.04%-0.56%)]和-6.99 mmol/mol(-0.64%)[95%CI -11.79至-2.19 mmol/mol(-1.08%至-0.20%)]。
研究结果表明,向成人护理的过渡可能会对患有糖尿病的青少年的血糖控制产生负面影响,而结构化的过渡计划可以抵消这种影响并预防不良后果。需要进一步研究以制定优化过渡干预措施的循证指南。